Cerebrospinal Fluid Biomarkers for Diagnosis and the Prognostication of Acute Ischemic Stroke: A Systematic Review

Despite the high incidence and burden of stroke, biological biomarkers are not used routinely in clinical practice to diagnose, determine progression, or prognosticate outcomes of acute ischemic stroke (AIS). Because of its direct interface with neural tissue, cerebrospinal fluid (CSF) is a potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Naik, Anant, Adeleye, Olufunmilola, Koester, Stefan W., Winkler, Ethan A., Hartke, Joelle N., Karahalios, Katherine, Mihaljevic, Sandra, Rani, Anupama, Raikwar, Sudhanshu, Rulney, Jarrod D., Desai, Shashvat M., Scherschinski, Lea, Ducruet, Andrew F., Albuquerque, Felipe C., Lawton, Michael T., Catapano, Joshua S., Jadhav, Ashutosh P., Jha, Ruchira M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341720/
https://www.ncbi.nlm.nih.gov/pubmed/37446092
http://dx.doi.org/10.3390/ijms241310902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341720/
https://www.ncbi.nlm.nih.gov/pubmed/37446092
http://dx.doi.org/10.3390/ijms241310902

Ejemplares similares